Clinical Trials Related to Crohn's Disease

Related studies linked through entity extraction aliases.

A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Quality of Life in Pediatric Inflammatory Bowel Disease

Status: COMPLETED
Phase: N/A

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

Status: COMPLETED
Phase: PHASE2

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Remission in Subjects With Crohn's Disease, 1 Year Phase

Status: COMPLETED
Phase: PHASE3

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Status: COMPLETED
Phase: PHASE3

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

Status: COMPLETED
Phase: PHASE3

CP-461 for the Treatment of Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Multicenter Trial For Patients With Acute Crohn's Disease

Status: COMPLETED
Phase: PHASE2

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Status: COMPLETED
Phase: PHASE3

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Status: COMPLETED
Phase: PHASE3

G-CSF to Treat Crohn's Disease

Status: COMPLETED
Phase: PHASE1

Monoclonal Antibody Treatment of Crohn's Disease

Status: COMPLETED
Phase: PHASE1

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

Status: COMPLETED
Phase: PHASE3

Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's Disease

Status: COMPLETED
Phase: NA